NextCure, Inc. Common Stock (NASDAQ: NXTC) last traded at $6.29, up 0.64% on the session. The quote above updates while this page is open; the figures below are drawn from NextCure, Inc. Common Stock’s own filings and are restated only when a new one is published.
NextCure, Inc. Common Stock trades on NASDAQ under the ticker NXTC. Its market capitalisation is $28.79 million.
Valuation measures for NextCure, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $28.79M |
|---|---|
| Enterprise value | $24.00M |
| Price / book | 2.37 |
| Beta | 2.05 |
Trailing-twelve-month figures tagged in NextCure, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$42.75M |
|---|---|
| EPS (TTM) | -$8.33 |
| Return on equity | -351.86% |
| Cash | $15.26M |
Range and volume for NXTC over the past 52 weeks.
| 52-week high | $15.74 |
|---|---|
| 52-week low | $1.55 |
| Volume | 36.4K |
| Average volume | 2.17M |
| Previous close | $6.25 |
Dividend history for NextCure, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.